Factors Influencing Colorectal Cancer Screening Participation by Gimeno García, Antonio Z.
Hindawi Publishing Corporation
Gastroenterology Research and Practice
Volume 2012, Article ID 483417, 8 pages
doi:10.1155/2012/483417
Review Article
Factors InﬂuencingColorectal Cancer ScreeningParticipation
AntonioZ. Gimeno Garc´ ıa
Department of Gastroenterology, University Hospital of Canary Islands, 38320 Tenerife, La Laguna, Spain
Correspondence should be addressed to Antonio Z. Gimeno Garc´ ıa, antozeben@gmail.com
Received 14 September 2011; Accepted 18 October 2011
Academic Editor: Enrique Quintero
Copyright © 2012 Antonio Z. Gimeno Garc´ ıa. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Colorectal cancer (CRC) is a major health problem worldwide. Although population-based CRC screening is strongly recom-
mended in average-risk population, compliance rates are still far from the desirable rates. High levels of screening uptake are
necessary for the success of any screening program. Therefore, the investigation of factors inﬂuencing participation is crucial prior
to design and launches a population-based organized screening campaign. Several studies have identiﬁed screening behaviour
factors related to potential participants, providers, or health care system. These inﬂuencing factors can also be classiﬁed in non-
modiﬁable (i.e., demographic factors, education, health insurance, or income) and modiﬁable factors (i.e., knowledge about CRC
and screening, patient and provider attitudes or structural barriers for screening). Modiﬁable determinants are of great interest
as they are plausible targets for interventions. Interventions at diﬀerent levels (patient, providers or health care system) have
been tested across the studies with diﬀerent results. This paper analyzes factors related to CRC screening behaviour and potential
interventions designed to improve screening uptake.
1.Introduction
Colorectal cancer (CRC) is the third leading cancer world-
wide in terms of incidence accounting for 1.2 million
new cases in 2008 (9.7% of total cancers) and the most
common malignancy in developed regions (727.000 cases).
CRC mortality rates rank fourth after lung, stomach, and
liver cancer accounting for 608.000 deaths in 2008 and 8%
of all cancer deaths [1].
The eﬃcacy of CRC screening in terms of reduction of
incidence and mortality rates has been shown in randomized
controlled trials [2–6]. In fact, medical organizations and
practice clinical guidelines recommend screening in average-
risk population [7–9]. In this way, the most extended CRC
screening strategies are based either on annual or biennial
faecal occult blood tests (FOBTs), with colonoscopy reserved
for patients testing positive, or on endoscopic procedures
performed as the primary screening tool performed once
only every ﬁve years (sigmoidoscopy) or every ten years
(colonoscopy). In addition, other screening procedures such
as CT colonography and faecal DNA analysis have been
recently recommended by some associations [8, 9] although
available evidence has been considered insuﬃcient by others
[7].
Screening uptake, deﬁned as a cross-sectional assessment
of compliance is a critical determinant of success for
any population-based screening program. High rates of
participation has been consistently associated with screening
eﬃcacy in terms of mortality reduction as well as cost-
eﬀectiveness [10]. This assumption is particularly certain in
the case of FOBT-based screening in which recommended
intervalsareshorterthanforotherscreeningstrategies(every
1o r2y e a r s )[ 11, 12].
Recently, a report from the European Commission
considered a minimum uptake of 45% in average-risk popu-
lation as an acceptable goal and 65% as a desirable rate [13],
whereas for the American Cancer Society the desirable goal
is 75% of the average-risk population [14]. However, despite
the available evidence and speciﬁc guidelines, CRC screening
rates remain far from these aims, although a considerable
variability exists around the world. In this way, population-
based FOBTs and sigmoidoscopy programmes ranged from
7.2% to 90.1% and from 7% to 55%, respectively, in
European countries. In the USA, according to the National2 Gastroenterology Research and Practice
HealthInterviewtheproportion ofadultsolderthan50years
who had had a recent screening test ranged from 53% to
73% [14]. However, participation rates for CRC screening
are markedly lower than those of other recommended adult
preventive services[15].Therefore,it is important to identify
predictors of screening uptake and develop interventional
strategies for promoting screening behaviours.
2.Predictorsof ScreeningUptake
Muchattentionhasbeengiventoinvestigatefactorsinﬂuenc-
ing CRC screening participation in average-risk population.
A practical way to classify these factors is in non-modiﬁable
factors (i.e., demographics, income, educational level, med-
ical insurance, or family history) and modiﬁable factors,
deﬁned as those susceptible of intervention. Theories of
health behaviour or theoretical models have been developed
to understand why people do or do not practice diﬀerent
health behaviours, identifying modiﬁable factors which may
be plausible targets of interventional strategies [16, 17].
These factors include knowledge about CRC and screening,
perception of risk for developing a CRC, and beneﬁts
and barriers against screening or intention to be screened
[18]. Therefore, theoretical models have a dual purpose,
“explanatory” and “interventionist”. Hereafter, we describe
the factors inﬂuencing CRC screening.
2.1. Sociodemographic Factors. Mixed results have been re-
portedregardingtheinﬂuenceofgenderinscreeningpartici-
pation.Although,overall,menlooktoparticipatemoreoften
than women in CRC screening, diﬀerences have been found
dependingonthecountryandscreeningstrategy.Inthisway,
ar ec entsyst ematicr eview[19]showedahigherparticipation
of women in FOBTs-based screening programmes carried
out in Europe or Australia. Other studies suggest a higher
use of endoscopy among men [20]. In USA, the Behav-
ioral Risk Factor Surveillance System (BRFSS) surveys have
consistently reported greater prevalence of CRC test, used
among men compared with women [21]. However, generally
in pooled analysis data, gender tended to be not signiﬁcant
[10].
Several studies have addressed the association between
ageandscreeninguptake[22–26].InUSA[24,25],screening
uptake was superior in elderly (≥65 years) people reporting
a peak at 75 years and decreasing around 80–85 years. This
ﬁnding could be explained, at least in part, because Medicare
covers all recommended screening strategies in people older
than 65 years, overcoming the economic barrier. However,
the same observation was found in a randomized study
performed in Italy [27], where men and women aged 65
years or older experienced a signiﬁcant increase in screening
uptake as compared to younger invitees.
Disparities in screening uptake have been consistently
reported in ethnic minorities across the studies [14, 21,
28, 29]. The knowledge of barriers in these groups are
of great interest to develop speciﬁc intervention strategies.
Low income and low educational level have been associated
with poor participation rates in minority ethnic groups
[28, 29]. These factors could be more important in countries
without a universal health coverage. In this regard, screening
uptake has been consistently reported lower among minority
groups as African Americans or Hispanics in USA [14, 21].
These data contrast with the higher reported incidence and
mortality rates observed in African Americans compared
with white population (20% and 45% higher incidence
and mortality rate of CRC, resp.) [28, 29]. Other factors,
such as language diﬃculties and the expression of culturally
inﬂuenced health beliefs have been reported in diﬀerent
countries as barriers, independent of the health care system
[30, 31]. In this way, information about test procedures
and beneﬁts of CRC screening provided by a native-
speaking health educator has been suggested as a facilitator
for increasing screening uptake in minority ethnic groups
[32].
A low socioeconomic status (income, unemployment,
educational level, and residence) has been associated with
lower screening participation in many studies [14, 21, 33,
34]. This factor is more important in countries in which
health services are not government funded. Data coming
from the BRFSS surveys [21] consistently report a lower
prevalence of CRC screening in those groups with lower
hosehold incomes, persons with no health insurance, and
unemployed. Lower education, assessed in diﬀerent studies
as less than high school education or having few years of
education, has also been reported as a barrier for screening
[15, 20, 29] regardless the type of screening strategy used
[35]. In an European study carried out in 953 average-risk
participants, the ever use of CRC screening being up-to-date
screening was more than four times higher among partic-
ipants with high education level [15]. Although an urban
area of residence have been associated with higher rates of
screening uptake in US studies [28, 36], contradictory results
has been found in Europe [15, 37, 38]. For example, whereas
a Swedish study found higher CRC screening uptake in rural
areas [37], two Spanish studies [15, 38] did not ﬁnd any
association between willingness to be screened or screening
uptake and the area of residence.
Married people have been shown to be more compliant
with healthier behaviour advise elsewhere [39]. In a large
European study carried out in UK [40], the authors found
that controlling by age and educational level, married cou-
plesweremorewillingtotakepartinscreeningprogramsand
presented higher attendance screening rates than those non-
married. Invitations of both partners increased screening
participation rates.
Lifestyleandhealthfactorshavealsobeenassociatedwith
screeninguptake.Forexample,currentsmokinghabit,which
has been considered as an indicator of willingness to engage
inpreventivehealthbehaviour,hasbeenassociatedwithpoor
CRC screening adherence, whereas screening rates increased
instudiesreportingparticipationinformersmokers[41,42].
However, this ﬁnding has not been consistently found across
the studies [15].
Inconsistent results have also been obtained regarding
the eﬀect of comorbidity on screening behavior, and, in
consequence, it has been suggested that the eﬀect of speciﬁc
diseases should be studied separately [41, 43]. Health
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usual source of care have been associated with higher rates
of screening uptake [15, 42]. In a nationwide US survey
carried out in a representative sample of 61.068 participants
aged ≥50yr [42], routing doctor’s visit in the last year was
the most important predictive factor of up-to-date CRC
screening in the multivariate analysis (OR 3.5, 95% CI (3.2–
3.8)) regardless of the screening strategy used. Adherence to
other cancer screening behaviours such as prostate cancer
screening in men or breast cancer in women has also
been positively associated with CRC screening uptake and
speciﬁc studies have already been carried out [44, 45]. In
a large survey study performed in men to investigate the
eﬀect of prostate cancer screening in CRC screening uptake
[45], adherence to prostate cancer screening exerted the
largest independent eﬀe c to nC R Ca d h e r e n c er e g a r d l e s so f
the method used for screening (prostate-speciﬁc antigen or
digitalrectalexam)(OR3.51,CI95%(3.30–3.73)).Similarly,
in the BRFSS, adherence with either cervical cancer or
breast cancer screening in women ≥50yr, was independent
predictor of an CRC screening (OR 1.88, P<0.001) [44].
2.2. Health Care System and Provider Factors. Health care
providers play a key role in the screening behaviour process
by increasing awareness about CRC and screening tests
in participants, reducing perceived barriers and increasing
perceived beneﬁts of screening tests. Physician recommen-
dation has shown a strong correlation with CRC screening
behaviours across the studies [46–48]. For example, in a
random-digit-dial survey carried out in USA involving 1002
participants ≥50yr [48], clinician’s recommendations were
the most important independent predictor of up-to-date
CRC screening either in participants were younger or older
than 65yr (OR 13.4, CI 95% (7.2–25) and OR 12.4 CI 95%
(5.7–27.1), resp.).
In a recent national representative survey of 1266 US
physicians [49], 95% and 80% routinely recommend screen-
ing colonoscopy or FOBT to asymptomatic, average-risk
patients, respectively. Interestingly, the most frequent prac-
tice was to recommend two modalities (56%), with FOBT
and colonoscopy being the most commonly-recommended
tests (50%). In fact, fewer than 10% routinely recommend
all test modalities. This aspect is of great importance as
several studies have reported the preferences of average-
risk population for diﬀerent CRC screening tests. Unlike
family-risk population for CRC, average-risk population
seem to prefer noninvasive testing [50]. Therefore, the
clinician’s preferences for more invasive tests could be a
barrier against screening. Recent evidence suggests that
immunochemicalFOBTcouldbebetteracceptedthanguaiac
occult blood tests because of a lower number of tests
required, the lack of dietary and drug restrictions, and easier
and less unpleasant sampling methods [51, 52]. Oﬀering
available recommended strategies and discussing beneﬁts
and drawbacks with patients have been suggested as the most
eﬀective procedure to achieve high participation rates [49].
Health system factors have been associated with CRC
screening uptake and physician recommendation [53, 54].
Apart from the lack of insurance previously commented,
coverageforaccessingtothescreeningservice,lackoftimeto
discuss CRC screening with the patient, or lack of physician’s
reminders have been consistently reported as barriers [53,
54].
2.3. Psychosocial Factors. Psychosocial factors involve those
related to knowledge about CRC and screening, risk percep-
tion of CRC, and perceived barriers and beneﬁts.
2.3.1. Knowledge about CRC and Screening. Knowledge
about CRC and screening has been assessed in diﬀerent
ways across the studies [15, 18, 38, 55–57], including
questions about risk factors for developing CRC, incidence,
prognosis, age-related risk, warning signs or symptoms, and
knowledge about recommended CRC screening tests. The
lack of knowledge on CRC and screening has been suggested
as a prominent barrier to screening adherence [15, 38].
It could be a more important barrier in areas with an
opportunistic screening than in those with well-organized
programs [58] and it has been reported as a major barrier
among minority ethnic groups [59]. In a prospective study
carried out in Spain [38], awareness of risk factors (OR
2.32, 95% CI (1.49–3.61); P<0.001) and CRC signs or
symptoms (OR 1.65, 95% CI (1.03–2.64); P = 0.04) were
independent predictors for intention to participate in CRC
screening. These authors reported in a later study [15] that
knowledge of CRC symptoms was associated with having
ever used either CRC procedures (OR 6.46, CI 95% (4.28–
9.74); P<0.001) or up-to-date screening (OR 7.23, CI 95%
(4.36–11.98); P<0.001).
The relative low public awareness about CRC in Euro-
pean studies contrast with data reported in US population.
For example, an Irish study [60] reported that only 26% of
patients with CRC could name a CRC symptom, compared
with 53% and 71% for lung and breast cancer, respectively.
In a recent British population-based sample, recall of cancer
warningsignsusinganopenquestionwaslessthan30%[61].
In Spain, awareness of at least one warning sign or symptom
related to CRC ranged from 21% to 56%. [15, 38]. However,
knowledge of CRC screening tests in some states of USA was
over 80% [46].
2.3.2. Risk Perception of CRC. High-risk perception of devel-
oping CRC have been frequently associated with higher
screening participation rates. For example, in one study
carried out in a large representative sample of UK, partici-
pants who answered that their risk was higher than average-
risk population were more willing to participate in CRC
screening (98%) than those who answered same risk (84%)
or lower risk (74%) [62]. In addition, unhealthy behaviours
such as smoking or sedentary has been associated with a
higher perception of risk [63, 64]. Similarly, the presence of
bowel symptoms, comorbidity, high body mass index, and
anxiety has also been associated with increased intention
to participate [63, 64]. The lack of recognition of cancer
risk has been suggested as a barrier of low participation in
cancer screening among nonwhite groups [63]. However, the
association between screening uptake and high perception4 Gastroenterology Research and Practice
risk has not been consistently found across the studies [15,
38].
2.3.3. Beneﬁts and Perceived Barriers against CRC Screening.
Although diﬀerent theoretical models have been developed
in order to achieve a better understanding of health
behaviour, all of them identify attitudes as important
predictors of intention to screening and screening uptake.
One of the most popular theoretical models is the Health
Belief Model (HBM) [16]. This model theorizes on people’s
beliefs regarding the risk for a disease or health problem,
and according to their perceptions on the beneﬁts of
taking actions to avoid it, analyzes their readiness to take
action. In this way, people with negative attitudes such
as embarrassment, anxiety, disinterest, fear of cancer or
screening, subjective perception of pain or danger about
screening, lack of time, feeling healthy, apprehensions about
the bowel preparation, laxatives or insertion of a tube, and
discomfort are more reluctant to participate in screening
programs [18, 56, 65–67]. In a recent study performed
in Spain [56], fear to CRC or to screening tests and
embarrassment were the main barriers that contributed to a
lower participation. This study also suggested that perceived
barriers could be more important than beneﬁts in predicting
CRC screening. A recent systematic review focused on
screening barriers in participants over 65 years found that
the most commonly reported barriers related to screening
tests were unpleasantness, discomfort, and perceived risk
associated with performing tests [68]. Some studies have
also suggested that barriers to screening are not homogenous
across screening tests and that test-speciﬁc barriers warrant
consideration in designing strategies to promote screening
[69].
More barriers have been detected in minority ethnic
groups such as African Americans, Asian people, or His-
panics [59, 63, 70]. A recent nationwide study focused
on awareness of CRC, and attitudes to sigmoidoscopy
screening carried out in UK [59] showed that the most
important barrier against screening diﬀered between white
and nonwhite participants. Lack of time was the major
limiting factor in white participants whereas embarrassment
predominated in nonwhite invitees. Attitudes have also been
shown to vary depending on socioeconomic position, with
negative attitudes overrepresented in lower socioeconomic
a n dl e s se d u c a t e dg r o u p s[ 18, 71].
3. Interventions to Promote CRC
ScreeningUptake
Interventions aimed at increasing CRC screening uptake can
be classiﬁed into three categories: those that target patients,
those that target providers, and those targeting health sys-
tems and communities.
3.1. Interventions Targeting Patients. The beneﬁt of interven-
tion targeting patients, deﬁned as an increment in screening
participation, has not always been demonstrated, probably
because of the heterogeneity of the studies and several types
of interventions used. Patient reminders consist of written or
oral information (i.e., phone calls) reminding the necessity
of undergoing screening to potential participants [72, 73].
The aim of this intervention is to schedule an appointment
with the health care provider in order to demand CRC
screening. In general, patient reminder-based studies have
shown moderate eﬃcacy for increasing screening uptake
[72–75]. In a recent study [72], 1546 participants were
randomized to a control group; a standard group (invitation
letter, FOBT, and reminder letter); a tailored intervention
(standard group intervention and discussion about personal
barriers); or a tailored intervention and reminder phone
call. One year later, screening uptake was signiﬁcantly higher
in those groups which received reminders compared to the
control group (33% versus 46%, 44%, and 48%, resp.). It has
alsobeensuggestedthatthewayinwhichscreeningisoﬀered
to the population may determine screening acceptance.
Particularly, two randomized studies have shown that direct
mailingofaFOBTkitisaneﬃcientwaytoincreasescreening
participation in the average-risk population [27, 74].
An association has been found between lack of knowl-
edgeaboutCRCandnegativeattitudes,unwillingnesstopar-
ticipate in CRC screening, and ﬁnally screening behaviours
[18, 56, 76]. Because of the positive relationship between
screening uptake and knowledge about CRC and screening,
several studies have assessed the impact of educational
interventions focused on average-risk screening population.
The purposes of these studies are increasing awareness on
CRC and screening and motivating people to be screened. It
has been suggested that high rates of screening uptake can be
achieved by modifying the phases of the “behavior process”,
that is, knowledge about the most important featuresof CRC
and screening, attitudes (reducing barriers and increasing
perceived beneﬁts), and intention to undergo screening
[18, 56]. In some educational interventions participants are
provided with some type of educational material including
visual images or videotapes [56, 77, 78], educational leaﬂets
[79], posters and calendars [80]. Speciﬁc interventions have
been designed to increase screening uptake in minority eth-
nic groups [81, 82]. For example, a patient navigator, deﬁned
as a health educator trained in providing better access to
healthcare services (i.e., scheduling procedures, educating
patients, and explaining instructions for colonoscopy or
FOBT) has been demonstrated to be useful for increasing
CRC screening uptake in ethnic minority groups [82]. In
general a combination of interventions may have a greatest
impact on screening rates [83].
3.2. Interventions Targeting Providers. Participant’s compli-
ance is usually associated with provider’s motivation [84].
The aim of the interventions targeting providers is to
increase delivery of recommended cancer screening services
by providers. Similarly to interventions targeting patients,
it has been suggested that reducing barriers and increasing
positive attitudes as well as intentions about screening would
have a positive impact on screening test recommendation
by providers. The desired eﬀect is to stimulate ordering
screening tests and ﬁnally to increase test completion [85].
Interventions focused on providers include: provider audit
and feedback, incentives, and reminders. Regarding providerGastroenterology Research and Practice 5
auditandfeedbackinterventions,medicalrecordsareusually
analyzed before and after intervention to assess performance
of delivering or oﬀering screening tests to patients. A recent
systematic review [86] evaluated the eﬀect of this interven-
tion in completion FOBT [87–89] and sigmoidoscopy [88].
Whereas the completion of FOBT screening increased 12
to 23 percentage points, no eﬀect was found in individuals
invited to screening sigmoidoscopy. The conclusion was
that provider audit and feedback intervention are eﬀective
for increasing CRC screening uptake with FOBTs, but the
current evidence is insuﬃcient for other screening strategies.
Incentive interventions try to motivate providers with
direct or indirect rewards (usually economic incentives) to
promote CRC screening in their patients. However, these
studies are scarce in the literature and poorly eﬀective [90].
In one study [90], 52 primary care sites were randomized to
the intervention or standard care. Intervention consisted of a
ﬁnancial award and an audit and feedback intervention. No
signiﬁcant diﬀerences in screening compliance were found
between both groups.
Little evidence supports the eﬃcacy of physician
reminder-based interventions [91]. In one study [73], 110
physicians and 21.860 patients were randomized to receive
reminders or standard care. Whereas screening rates were
higher for patients who received mailings compared to those
who did not (44.0% versus 38.1%, P<0.001), they were
similar among patients of physicians receiving electronic
reminders and the standard group (41.9% versus 40.2%,
P = 0.47).
3.3. Organizational Interventions to Improve Access. Improv-
ing the referral of patients for screening [92], delivery
capacity of services for screening or patient access reducing
costs for participants or identifying someone to help patients
to navigate the health care system [93] has been associated
with an increased screening acceptance. The development
of special clinics devoted to screening, the use of planned
care screening visits involving physicians and health or non-
health professionals could increase screening rates reducing
the barrier of physician’s lack of time [83]. However, an
important ﬁnancial investment is necessary and it has been
reported as a major barrier [94].
4. Conclusion
Underuse of population-based CRC screening is a multi-
factorial problem involving patients, providers, and the
organizational screening process. Plausible target factors for
interventions aimed at increasing compliance have been
identiﬁed at diﬀerent levels. Speciﬁc interventions targeting
these factors have been designed to increase screening
uptake. However, they have had diﬀerent success across the
studiesdependingonthescreeningstrategyandtheinterven-
tionused.Despitetheeﬀorts,theimpactonscreeninguptake
has been low or moderate. A better knowledge on factors
associated with screening compliance and development of
moreeﬃcientinterventionsarewarrantedinordertoachieve
higher rates of CRC screening uptake.
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